Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Frontiers in Immunology|January 26, 2026
B-cell-driven relapse and anti-CD20 rescue therapy after Alemtuzumab in RRMS: case report and literature reviewPietro Antonio Bruno, Stefania Barone, Angelo Pascarella, et al.Neuro-Degenerative Diseases|November 13, 2019
Assessment of the Corticospinal Tract Profile in Pure Lower Motor Neuron Disease: A Diffusion Tensor Imaging StudyAlessia Sarica, Paola Valentino, Rita Nisticò, et al.Reviews on Recent Clinical Trials|June 20, 2022
Hepatic Encephalopathy by Manganese Deposition: A Case Report and a Review of LiteratureLudovico Abenavoli, Giulia Fabiano, Anna Caterina Procopio, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 30, 2026
Nabiximols improves sleep architecture in multiple sclerosis: A prospective polysomnographic studyFrancesco Fortunato, Adriana Saraceno, Stefania Barone, et al.Journal of Neurology|July 28, 2018
Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis studyStefania Barone, Maria Eugenia Caligiuri, Paola Valentino, et al.Human Brain Mapping|September 24, 2016
The corticospinal tract profile in amyotrophic lateral sclerosisAlessia Sarica, Antonio Cerasa, Paola Valentino, et al.Brain Imaging and Behavior|July 12, 2018
Evaluation of machine learning algorithms performance for the prediction of early multiple sclerosis from resting-state FMRI connectivity dataValeria Saccà, Alessia Sarica, Fabiana Novellino, et al.Neuroimage. Clinical|January 23, 2015
The relationship between regional microstructural abnormalities of the corpus callosum and physical and cognitive disability in relapsing-remitting multiple sclerosisMaria Eugenia Caligiuri, Stefania Barone, Andrea Cherubini, et al.Multiple Sclerosis and Related Disorders|December 23, 2017
Hepatic microabscesses during CMV reactivation in a multiple sclerosis patient after alemtuzumab treatmentStefania Barone, Sara Scannapieco, Carlo Torti, et al.Brain Research|June 24, 2025
Fatigue in natalizumab-treated Multiple Sclerosis patients: How much is wearing-off to blame?Giuseppe Magro, Stefania Barone, Angelo Pascarella, et al.Pageof 2